Art

J-GLOBAL ID：201902239229100941   Reference number：19A0610622

Cyclosporine Therapy in Patients with Transfusion-independent Non-severe Aplastic Anemia: A Retrospective Analysis

輸血非依存性非重症再生不良性貧血患者におけるシクロスポリン療法:後ろ向き分析

Author (7)： Matsuda Kensuke (Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan) ,  Koya Junji (Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan) ,  Arai Shunya (Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan) ,  Nakazaki Kumi (Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan) ,  Nakamura Fumihiko (Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan) ,  Kurokawa Mineo (Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Japan) ,  Kurokawa Mineo (Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Japan)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 58  Issue： 3  Page： 355-360(J-STAGE)  Publication year： 2019 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： Hematocytopenia ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0610622&from=J-GLOBAL&jstjournalNo=U0033A") }}

Author keywords (5)： aplastic anemia ,  immunosuppressive therapy ,  transfusion-independent ,  non-severe ,  natural course

JST classification (2)： Drug therapy(=pharmacotherapy)for hematologic diseases in general  (GK05020P) ,  Clinical application of immunotherapeutic agents and blood preparations  (GW22020O)

Substance index (1)： Ciclosporin

Reference (16)：

• 1. Kojima S, Hibi S, Kosaka Y, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 96: 2049-2054, 2010.
• 2. Fuhrer M, Rampf U, Baumann I, et al. Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood 106: 2102-2104, 2005.
• 3. Marsh J, Schrezenmeier H, Marin P, et al. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 93: 2191-2195, 1999.
• 4. Marsh JC, Ball SE, Darbyshire P, et al. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 123: 782-801, 2003.
• 5. Scheinberg P, Young NS. How I treat acquired aplastic anemia. Blood 120: 1185-1196, 2012.

Terms in the title (7)： 輸血 ,  非依存性 ,  重症再生不良性貧血 ,  患者 ,  シクロスポリン ,  療法 ,  後ろ向き分析